HomeCTX • TSE
Crescita Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 6.90M | 46.07% |
Operating expense | 3.14M | -1.17% |
Net income | -162.00K | -8.00% |
Net profit margin | -2.35 | 25.87% |
Earnings per share | — | — |
EBITDA | 94.50K | -41.58% |
Effective tax rate | 7.95% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.28M | -1.19% |
Total assets | 21.78M | -11.47% |
Total liabilities | 5.95M | 2.96% |
Total equity | 15.83M | — |
Shares outstanding | 19.01M | — |
Price to book | 0.70 | — |
Return on assets | -1.59% | — |
Return on capital | -2.09% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -162.00K | -8.00% |
Cash from operations | 1.38M | 627.20% |
Cash from investing | -353.00K | -236.19% |
Cash from financing | -240.00K | 6.98% |
Net change in cash | 835.00K | 231.29% |
Free cash flow | 1.21M | 334.47% |
Previous close
$0.58
Day range
$0.58 - $0.58
Year range
$0.41 - $0.69
Market cap
11.04M CAD
Avg Volume
4.34K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
2016
Website
Employees
80
